Calyxt completes new scientific advisory board with key appointments

World-renowned plant-biochemistry experts named to calyxt's scientific advisory board chaired by company co-founder dan voytas, ph.d. new strategic initiative to identify high value plant-derived products utilizing calyxt's proprietary innovation platform roseville, mn / accesswire / march 2, 2021 /  calyxt, inc. (nasdaq:clxt), a plant-based technology company, has completed key appointments to its previously announced scientific advisory board (sab) to identify high value plant-derived product targets that will be produced utilizing calyxt's proprietary innovation platform.
CLXT Ratings Summary
CLXT Quant Ranking